These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3875399)

  • 21. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
    Zhao R; Assaraf YG; Goldman ID
    J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic correlates of methotrexate transport and therapeutic responsiveness in murine tumors.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1976 Mar; 36(3):1151-8. PubMed ID: 943237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of folate transport in rabbit reticulocytes.
    Bobzien WF; Goldman ID
    J Clin Invest; 1972 Jul; 51(7):1688-96. PubMed ID: 5032520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
    Kühnel JM; Chiao JH; Sirotnak FM
    J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships between carrier-mediated transport of folate compounds by L1210 leukemia cells: evidence for multiplicity of entry routes with different kinetic properties expressed in plasma membrane vesicles.
    Yang CH; Dembo M; Sirotnak FM
    J Membr Biol; 1983; 75(1):11-20. PubMed ID: 6887234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of non-physiological buffer systems in the analysis of methotrexate transport in L1210 cells.
    Henderson GB; Zevely EM
    Biochem Int; 1983 Apr; 6(4):507-15. PubMed ID: 6679721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate.
    Henderson GB; Suresh MR; Vitols KS; Huennekens FM
    Cancer Res; 1986 Apr; 46(4 Pt 1):1639-43. PubMed ID: 3948153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
    Spinella MJ; Brigle KE; Sierra EE; Goldman ID
    J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system.
    Sirotnak FM; Moccio DM; Yang CH
    J Biol Chem; 1984 Nov; 259(21):13139-44. PubMed ID: 6490649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
    Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
    J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
    Sierra EE; Brigle KE; Spinella MJ; Goldman ID
    Biochem Pharmacol; 1997 Jan; 53(2):223-31. PubMed ID: 9037255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similar specificity of membrane transport for folate analogues and their metabolites by murine and human tumor cells: a clinically directed laboratory study.
    Moccio DM; Sirotnak FM; Samuels LL; Ahmed T; Yagoda A; DeGraw JI; Piper JR
    Cancer Res; 1984 Jan; 44(1):352-7. PubMed ID: 6690047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750
    [No Abstract]   [Full Text] [Related]  

  • 37. Two-compartment behavior during transport of folate compounds in L1210 cell plasma membrane vesicles.
    Yang CH; Dembo M; Sirotnak FM
    J Membr Biol; 1982; 68(1):19-28. PubMed ID: 6980990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro.
    Samuels LL; Moccio DM; Sirotnak FM
    Cancer Res; 1985 Apr; 45(4):1488-95. PubMed ID: 3978616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.
    Zhao R; Assaraf YG; Goldman ID
    J Biol Chem; 1998 Apr; 273(14):7873-9. PubMed ID: 9525881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the amino acid 45 residue in reduced folate carrier function and ion-dependent transport as characterized by site-directed mutagenesis.
    Zhao R; Gao F; Wang PJ; Goldman ID
    Mol Pharmacol; 2000 Feb; 57(2):317-23. PubMed ID: 10648641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.